EG23373A - Process and intermediates. - Google Patents

Process and intermediates.

Info

Publication number
EG23373A
EG23373A EG20011065A EG20011065A EG23373A EG 23373 A EG23373 A EG 23373A EG 20011065 A EG20011065 A EG 20011065A EG 20011065 A EG20011065 A EG 20011065A EG 23373 A EG23373 A EG 23373A
Authority
EG
Egypt
Prior art keywords
intermediates
Prior art date
Application number
EG20011065A
Other languages
English (en)
Inventor
Robert Stevenson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9901292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG23373(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of EG23373A publication Critical patent/EG23373A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EG20011065A 2000-10-14 2001-10-10 Process and intermediates. EG23373A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0025221.3A GB0025221D0 (en) 2000-10-14 2000-10-14 New process

Publications (1)

Publication Number Publication Date
EG23373A true EG23373A (en) 2005-02-28

Family

ID=9901292

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20011065A EG23373A (en) 2000-10-14 2001-10-10 Process and intermediates.

Country Status (26)

Country Link
US (1) US7947667B2 (xx)
EP (2) EP1328538B1 (xx)
JP (2) JP4363846B2 (xx)
KR (2) KR100864266B1 (xx)
CN (1) CN1255425C (xx)
AR (2) AR034561A1 (xx)
AT (1) ATE403667T1 (xx)
AU (3) AU2001292132B2 (xx)
BR (1) BR0114649A (xx)
CA (1) CA2425572C (xx)
CY (1) CY1108398T1 (xx)
DE (1) DE60135240D1 (xx)
DK (1) DK1328538T3 (xx)
EG (1) EG23373A (xx)
ES (2) ES2309094T3 (xx)
GB (1) GB0025221D0 (xx)
IL (2) IL155172A0 (xx)
MX (1) MXPA03003302A (xx)
MY (2) MY145819A (xx)
NO (1) NO326020B1 (xx)
NZ (1) NZ525096A (xx)
PT (1) PT1328538E (xx)
SA (1) SA01220570B1 (xx)
SI (1) SI1328538T1 (xx)
WO (1) WO2002032922A1 (xx)
ZA (1) ZA200302526B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
GB0123961D0 (en) 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates
DE602005023877D1 (de) 2004-07-27 2010-11-11 Sicor Inc Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
US20100174101A1 (en) * 2007-09-24 2010-07-08 Xi'an Liband Pharmaceutical Co., Ltd. Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)- triene-3,17-beta-diol
EP2070942A1 (de) 2007-12-13 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Aromatisierung von 19-Nor-androst-4-en-3-onen zu Estra-1,3,5(10)-trienen
CN101525364B (zh) * 2008-03-07 2012-12-12 杭州九源基因工程有限公司 一种氟维司群的晶型及其制备方法
US8063249B1 (en) 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
CN102391341B (zh) * 2011-08-09 2013-05-22 福建省微生物研究所 制备6,7-脱氢-17β-烃酰氧基诺龙的方法
CN102600064A (zh) * 2012-03-31 2012-07-25 西安力邦制药有限公司 氟维司群或其衍生物缓释制剂及其制备方法
EP2909224B1 (en) 2012-10-22 2020-03-18 Intas Pharmaceuticals Limited An improved process for the preparation of fulvestrant
CN103788164A (zh) * 2012-10-31 2014-05-14 正大天晴药业集团股份有限公司 一种氟维司群的制备方法
CN103965280B (zh) * 2014-05-21 2016-04-20 天津孚音生物科技发展有限公司 一种氟维司群中间体的制备方法
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
CN104387435B (zh) * 2014-12-10 2017-05-10 天津孚音生物科技发展有限公司 一种化合物及其制备方法与应用
KR101640747B1 (ko) 2015-05-20 2016-07-19 이금운 확장 가능형 끼움식 엘이디 조명 등기구
CN107488205A (zh) * 2016-06-13 2017-12-19 重庆圣华曦药业股份有限公司 一种氟维司群有关物质的制备方法及其在制剂中的检测方法
CN110818764A (zh) * 2018-08-07 2020-02-21 重庆圣华曦药业股份有限公司 一种应用加料监测系统制备氟维斯群中间体的方法
CN111018936B (zh) * 2019-11-12 2021-10-29 广州曼翔医药有限公司 一种氟维司群有关物质e的合成方法
CN116535454A (zh) * 2023-04-28 2023-08-04 香港中文大学（深圳） 氟维司群类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7305171A (xx) * 1973-04-13 1974-10-15
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5595985A (en) * 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
US5211831A (en) * 1991-11-27 1993-05-18 Mcgean-Rohco, Inc. Process for extending the life of a displacement plating bath
DE19622457A1 (de) * 1996-05-24 1997-11-27 Schering Ag 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
CA2402524C (en) * 2000-03-31 2009-11-17 Richard P. Blye Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
GB0123961D0 (en) * 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates

Also Published As

Publication number Publication date
CA2425572C (en) 2010-03-09
US7947667B2 (en) 2011-05-24
ZA200302526B (en) 2004-02-16
ES2581379T3 (es) 2016-09-05
AU2001292132B2 (en) 2007-01-25
BR0114649A (pt) 2004-02-10
SA01220570B1 (ar) 2007-03-18
KR100864266B1 (ko) 2008-10-20
JP2009215303A (ja) 2009-09-24
MY145819A (en) 2012-04-30
DE60135240D1 (de) 2008-09-18
EP1328538A1 (en) 2003-07-23
DK1328538T3 (da) 2008-11-03
WO2002032922A1 (en) 2002-04-25
KR20030081319A (ko) 2003-10-17
EP1918295A3 (en) 2012-10-17
CY1108398T1 (el) 2014-02-12
ES2309094T3 (es) 2008-12-16
CA2425572A1 (en) 2002-04-25
GB0025221D0 (en) 2000-11-29
AU2007201740A1 (en) 2007-05-10
IL155172A0 (en) 2003-10-31
JP5133937B2 (ja) 2013-01-30
NO20031701L (no) 2003-05-23
CN1255425C (zh) 2006-05-10
IL155172A (en) 2012-04-30
NZ525096A (en) 2004-10-29
SI1328538T1 (sl) 2008-12-31
AR082409A2 (es) 2012-12-05
NO20031701D0 (no) 2003-04-11
JP4363846B2 (ja) 2009-11-11
PT1328538E (pt) 2008-09-30
MY149146A (en) 2013-07-15
EP1328538B1 (en) 2008-08-06
JP2004511567A (ja) 2004-04-15
US20050101583A1 (en) 2005-05-12
NO326020B1 (no) 2008-09-01
CN1479746A (zh) 2004-03-03
AR034561A1 (es) 2004-03-03
AU9213201A (en) 2002-04-29
EP1918295A2 (en) 2008-05-07
EP1918295B1 (en) 2016-04-06
MXPA03003302A (es) 2003-08-07
ATE403667T1 (de) 2008-08-15
KR20080056029A (ko) 2008-06-19
AU2007201740B2 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
MXPA02010604A (es) Barra para limpieza personal y proceso de preparacion.
GB0011120D0 (en) Process
EG23373A (en) Process and intermediates.
AU2001294549A1 (en) Process and intermediates
PL363702A1 (en) Chemical process and new intermediates
GB0023781D0 (en) Process
GB0020523D0 (en) Process
GB0013793D0 (en) Process
GB0010437D0 (en) Process
GB0123961D0 (en) Process and intermediates
GB0020021D0 (en) Process
GB0002201D0 (en) Process
MXPA03005569A (es) PROCEDIMIENTO MEJORADO PARA LA PREPARACION DE UN FARMACO ANTIMIGRAnOSO.
GB0014583D0 (en) Process
GB0014580D0 (en) Appatarus and process
GB0021488D0 (en) Process
GB0013791D0 (en) Process
GB0028523D0 (en) Process
GB0016633D0 (en) Process
GB0025310D0 (en) Process
ZA200002987B (en) Novel processes and intermediates.
GB0013204D0 (en) Novel process and intermediates
GB0006722D0 (en) Process
GB0001564D0 (en) Process
ZA200105584B (en) Process.